Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Cellular Analysis Platform

By Drug Discovery Trends Editor | October 7, 2008

Guava Technologies Cellular Analysis PlatformGuava Technologies, Inc. has teamed up with the Hudson Control Group to provide scientists with an integrated cellular analysis platform that delivers new levels of throughput and ease-of-use for cell counting, viability, and apoptosis. This system links a Guava EasyCyte Plus Flow Cytometer, a Hudson Control PlateCrane EX Robotic Arm, and a Hudson Control micro10 Liquid Dispenser, all controlled using integration software from both Hudson Control Group and Guava Technologies. The integration allows users to perform automated sample prep and analysis for a range of Guava Turnkey Assays in 96-well format.

The Guava EasyCyte Plus System has a number of features including a high throughput, multicolor detection for cell analysis and counting, including Guava Technologies turnkey assays for cell counting and viability, apoptosis, and cell cycle. One feature, the simultaneous four-color fluorescence detector, allows users to acquire more data from a single well in a 96-well plate, simplifying the process of capturing intra- and extracellular events.

www.guavatechnologies.com 

Published in Drug Discovery & Development magazine: Vol. 11, No. 10, October, 2008, p.8.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50